Michael Stucky

Michael Stucky is the Chief Investment Officer and Venture Partner at Serpentine Ventures, where he focuses on scouting and strategic partnerships for early-stage companies. He concurrently serves as the Co-founder and Chairman of Auxivo AG and holds the Chairman of the Board position at FenX. Previously, Stucky was the Co-founder and Chief Financial Officer of GlycoVaxyn AG, a biotechnology company he helped lead to a successful acquisition by GSK in February 2015. His extensive entrepreneurial background also includes serving as the Co-founder and Executive Director of Anjarium Biosciences. For nearly a decade, he has mentored emerging talent and guided deep tech spin-offs at ETH Zurich and Innosuisse, while frequently speaking on funding growth at industry events like Podim. Stucky currently focuses on deep tech investments, venture capital portfolio triage, and scaling innovative biotechnology startups.